Linsitinib (OSI-906) versus placebo for patients with locally advanced or metastatic adrenocortical carcinoma: a double-blind, randomised, phase 3 study.
暂无分享，去创建一个
T. Choueiri | E. Baudin | M. Fassnacht | J. Gilbert | G. Hammer | C. Ronchi | D. Quinn | F. Worden | M. Demeure | M. Kroiss | A. Berruti | M. Terzolo | H. Haak | S. Poondru | R. Rorig | A. Stephens | Jihong Chen | Elizabeth Hesseltine | Tanya E. Fleege